Phosphoproteomic analyses reveal that galectin-1 augments the dynamics of B-cell receptor signaling

Journal of Proteomics

Volumn 103, Issue , 2014, Pages 241-253

  Tsai, Chih Ming ^a   Wu, Hsin Yi ^b   Su, Tseng Hsiung ^a   Kuo, Chu Wei ^c   Huang, Han Wen ^a   Chung, Cheng Han ^a,d   Chen, Chien Sin ^a   Khoo, Kay Hooi ^a,c   Chen, Yu Ju ^a,b   Lin, Kuo I ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b INSTITUTE OF CHEMISTRY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

B cell activation; B cell receptor; Galectin 1; Phosphoproteome

Indexed keywords

B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; GALECTIN 1; GRANZYME A; INTERLEUKIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PHOSPHOPEPTIDE; PHOSPHOSERINE; PHOSPHOTHREONINE; PHOSPHOTYROSINE; PROTEIN KINASE SYK; TELOMERASE; ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHOPROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE ACTIVATION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DNA METHYLATION; ENDOPLASMIC RETICULUM; IMMUNOLOGICAL SYNAPSE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTES; GALECTIN 1; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PROTEOMICS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 84899801182     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.03.031     Document Type: Article

References (46)

1. Barondes S.H., Castronovo V., Cooper D.N., Cummings R.D., Drickamer K., Feizi T., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994, 76:597-598.
2. Leffler H., Carlsson S., Hedlund M., Qian Y., Poirier F. Introduction to galectins. Glycoconj J 2004, 19:433-440.
3. Liu F.T., Rabinovich G.A. Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci 2010, 1183:158-182.
4. Tsai C.M., Chiu Y.K., Hsu T.L., Lin I.Y., Hsieh S.L., Lin K.I. Galectin-1 promotes immunoglobulin production during plasma cell differentiation. J Immunol 2008, 181:4570-4579.
5. Zuniga E., Rabinovich G.A., Iglesias M.M., Gruppi A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J Leukoc Biol 2001, 70:73-79.
6. Croci D.O., Morande P.E., Dergan-Dylon S., Borge M., Toscano M.A., Stupirski J.C., et al. Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1. Leukemia 2012, 27:1413-1416.
7. Garner O.B., Baum L.G. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem Soc Trans 2008, 36:1472-1477.
8. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009, 9:338-352.
9. Rabinovich G.A., Toscano M.A., Jackson S.S., Vasta G.R. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol 2007, 17:513-520.
10. Elola M.T., Chiesa M.E., Alberti A.F., Mordoh J., Fink N.E. Galectin-1 receptors in different cell types. J Biomed Sci 2005, 12:13-29.
11. Fulcher J.A., Chang M.H., Wang S., Almazan T., Hashimi S.T., Eriksson A.U., et al. Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling. J Biol Chem 2009, 284:26860-26870.
12. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
13. Rowley R.B., Burkhardt A.L., Chao H.G., Matsueda G.R., Bolen J.B. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation. J Biol Chem 1995, 270:11590-11594.
14. Shiue L., Zoller M.J., Brugge J.S. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. J Biol Chem 1995, 270:10498-10502.
15. Johnson S.A., Pleiman C.M., Pao L., Schneringer J., Hippen K., Cambier J.C. Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases. J Immunol 1995, 155:4596-4603.
16. Gold M.R. Intermediary signaling effectors coupling the B-cell receptor to the nucleus. Curr Top Microbiol Immunol 2000, 245:77-134.
17. van Anken E., Romijn E.P., Maggioni C., Mezghrani A., Sitia R., Braakman I., et al. Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion. Immunity 2003, 18:243-253.
18. Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676-682.
19. Phan T.G., Gardam S., Basten A., Brink R. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J Immunol 2005, 174:4567-4578.
20. Phan T.G., Amesbury M., Gardam S., Crosbie J., Hasbold J., Hodgkin P.D., et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med 2003, 197:845-860.
21. Shirakawa A.K., Liao F., Zhang H.H., Hedrick M.N., Singh S.P., Wu D., et al. Pathway-selective suppression of chemokine receptor signaling in B cells by LPS through downregulation of PLC-beta2. Cell Mol Immunol 2010, 7:428-439.
22. Wang Y.T., Tsai C.F., Hong T.C., Tsou C.C., Lin P.Y., Pan S.H., et al. An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 2010, 9:5582-5597.
23. Tsou C.C., Tsai C.F., Tsui Y.H., Sudhir P.R., Wang Y.T., Chen Y.J., et al. IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics 2010, 9:131-144.
24. Olsen J.V., de Godoy L.M., Li G., Macek B., Mortensen P., Pesch R., et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005, 4:2010-2021.
25. Vizcaino J.A., Cote R.G., Csordas A., Dianes J.A., Fabregat A., Foster J.M., et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 2013, 41:D1063-D1069.
26. Zeeberg B.R., Feng W., Wang G., Wang M.D., Fojo A.T., Sunshine M., et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003, 4:R28.
27. Schwartz D., Gygi S.P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 2005, 23:1391-1398.
28. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., et al. Human Protein Reference Database-2009 update. Nucleic Acids Res 2009, 37:D767-D772.
29. Wang D., Feng J., Wen R., Marine J.C., Sangster M.Y., Parganas E., et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000, 13:25-35.
30. Xia X., Li L., Choi Y.S. Human recombinant IL-3 is a growth factor for normal B cells. J Immunol 1992, 148:491-497.
31. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002, 109:1625-1633.
32. Yamada T., Zhang K., Yamada A., Zhu D., Saxon A. B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination. Am J Respir Cell Mol Biol 2005, 32:388-394.
33. McAlees J.W., Sanders V.M. Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes. Mol Cell Biol 2009, 29:675-686.
34. Hong J.J., Yankee T.M., Harrison M.L., Geahlen R.L. Regulation of signaling in B cells through the phosphorylation of Syk on linker region tyrosines. A mechanism for negative signaling by the Lyn tyrosine kinase. J Biol Chem 2002, 277:31703-31714.
35. Manes N.P., Dong L., Zhou W., Du X., Reghu N., Kool A.C., et al. Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Mol Cell Proteomics 2011, 10. [M110 000927].
36. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003, 17:590-603.
37. Wang Y., Liang L., Esselman W.J. Regulation of the calcium/NF-AT T cell activation pathway by the D2 domain of CD45. J Immunol 2000, 164:2557-2564.
38. Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
39. Kurosaki T., Hikida M. Tyrosine kinases and their substrates in B lymphocytes. Immunol Rev 2009, 228:132-148.
40. Katagiri T., Ogimoto M., Hasegawa K., Arimura Y., Mitomo K., Okada M., et al. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells. J Immunol 1999, 163:1321-1326.
41. Keshvara L.M., Isaacson C.C., Yankee T.M., Sarac R., Harrison M.L., Geahlen R.L. Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J Immunol 1998, 161:5276-5283.
42. Wu H.Y., Tseng V.S., Liao P.C. Mining phosphopeptide signals in liquid chromatography-mass spectrometry data for protein phosphorylation analysis. J Proteome Res 2007, 6:1812-1821.
43. Bergstrom Lind S., Molin M., Savitski M.M., Emilsson L., Astrom J., Hedberg L., et al. Immunoaffinity enrichments followed by mass spectrometric detection for studying global protein tyrosine phosphorylation. J Proteome Res 2008, 7:2897-2910.
44. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003, 22:3876-3886.
45. Jung E.J., Moon H.G., Cho B.I., Jeong C.Y., Joo Y.T., Lee Y.J., et al. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 2007, 120:2331-2338.
46. Novak R., Dabelic S., Dumic J. Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochim Biophys Acta 1820, 2012:1383-1390.